CD38 and Miyoshi myopathy: They found that their modified KHYG-1 NK cells effectively mediate anti-MM activity, while there is low or no cytotoxicity against nonmalignant cells especially against T, and NK cells, with one remarkable exception: the elimination of CD38+ regulatory T cells.